Dear Tribal Leaders, Public Health Officials, and Indian Country Professionals,
On behalf of the White House COVID Response Team, please join us for a White House Tribal COVID-19 Update.
EVENT: White House Tribal COVID-19 Update
DATE: Wednesday, August 4th
TIME: 4:00 PM EST
REGISTRATION: REGISTER HERE
Please Note: This call is closed press and not for attribution.
–
The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for monoclonal antibodies to treat COVID-19 for certain patients. Monoclonal antibodies may be available through expanded access programs to treat COVID-19 for immunocompromised patients. However, the efficacy of use for immunocompromised patients is unclear.
During this COCA Call, presenters will discuss the FDA’s role in issuing EUAs for certain monoclonal antibodies, options for compassionate use, the process for ordering and distributing monoclonal antibodies, and current data on using monoclonal antibodies for both non-hospitalized and immunocompromised patients. Presenters will also cover preventing, diagnosing, and treating COVID-19 in immunocompromised patients, including the role of monoclonal antibodies, serologic testing, and potential third dose of COVID-19 vaccinations.
Webinar Link: https://www.zoomgov.com/j/1612254638?pwd=SmNaNlJEUWt3YWdBMGtNRjhxRlZ1UT09external icon
Passcode: 980771
Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 669 216 1590
or +1 551 285 1373
One-tap mobile:
US: +16692545252,,1612254638#,,,,*980771# or +16468287666,,1612254638#,,,,*980771#
Webinar ID: 161 225 4638
Elliot Raizes, MD
Task Force Lead
Health Services and Worker Safety Task Force
COVID-19 Response
Centers for Disease Control and Prevention
John Farley, MD, MPH
Director, Office of Infectious Diseases
Center for Drug Evaluation and Research
Office of New Drugs
U.S. Food and Drug Administration
Colin Shepard, MD
CDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)
Center for Preparedness and Response
Centers for Disease Control and Prevention
Rajesh Gandhi, MD
Director, HIV Clinical Services and Education, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School
Adi Gundlapalli, MD, PhD, MS
Chief Public Health Informatics Officer
Deputy Director, Public Health Science and Surveillance
Public Health Informatics Office
Center for Surveillance, Epidemiology, and Laboratory Services
Centers for Disease Control and Prevention
–
Every other Thursday at 4:00 PM-5:30 PM Eastern
A link to RSVP is provided shortly before each call and will be added here ASAP.
Note: You must RSVP to join the call. Upon successful registration, you will receive a confirmation email with dial-in instructions.
–
National Congress of American Indians (NCAI) and NAFOA will host a webinar featuring speakers discussing the new Tribal Government State Small Business Credit Initiative (SSBCI) with speakers from the Department of the Treasury (Treasury).
The webinar will provide information about the SSBCI program, how to file a Notice of Intent, and Treasury will answer participant questions about the program/application process.
Included as a provision in the American Rescue Plan Act, SSBCI funds tribal, state, and territory small business and support programs. SSBCI has at least $500 million allocated for Tribal Nations. To access this funding, Tribal Nations must provide Treasury with a Notice of Intent by August 16, 2021.
Stakeholders are invited to join Assistant Secretary for Health for the U.S. Department of Health and Human Services (HHS), Rachel L. Levine, M.D., Acting FDA Commissioner, Janet Woodcock, M.D., and Peter Marks, M.D., Ph.D., Director, FDA Center for Biologics Evaluation and Research, to discuss vaccine updates for younger children and adolescents.
One tap mobile: | US: +16692545252,,1607308686#,,,,*470339# or +16468287666,,1607308686#,,,,*470339# |
Meeting URL: | https://fda.zoomgov.com/j/1607308686?pwd=eHBJWGZWRjYwZWkrN0lFams1akIrZz09 |
Meeting ID: | 160 730 8686 |
Passcode: | 0N!Nns |
Join by Telephone | |
For higher quality, dial a number based on your current location. | |
Dial: | US: +1 669 254 5252 or +1 646 828 7666 or +1 551 285 1373 or +1 669 216 1590 or 833 568 8864 (Toll Free) |
Meeting ID: | 160 730 8686 |
Passcode: | 470339 |
–
The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for additional doses of mRNA COVID-19 vaccines for moderately to severely immunocompromised people. People with immunocompromising conditions or who take immunosuppressive medications or therapies are at increased risk for severe COVID-19. Studies indicate that some immunocompromised people have a reduced immune response following a primary COVID-19 vaccine series compared to vaccine recipients who are not immunocompromised. Studies have further demonstrated that an additional mRNA COVID-19 vaccine dose after an initial 2-dose primary mRNA COVID-19 vaccine series in some immunocompromised populations may enhance immune response.
During this COCA Call, presenters will discuss the current data on COVID-19 vaccines in immunocompromised people; the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and CDC’s guidance on additional COVID-19 doses in immunocompromised people.
Webinar Link: https://www.zoomgov.com/j/1602130331?pwd=RStLbjVHQWdzSENWNXlVOEh2QUJLUT09external icon
Passcode: 549822
Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 669 216 1590
or +1 551 285 1373
One-tap mobile:
US: +16692545252,,1602130331#,,,,*549822# or +16468287666,,1602130331#,,,,*549822#
Webinar ID: 160 213 0331
–
Join the Surgeon General on August 19 for a briefing and Q&A on the Biden Administration’s plan for COVID-19 vaccine boosters. Details on the event below:
COVID-19 Community Corps Call on Vaccine Boosters
Date: Thursday, August 19
Time: 1:00pm ET
RSVP here
Join the White House Office of Intergovernmental Affairs for a special edition of our Weekly Briefing Call featuring U.S. Department of Labor Secretary Martin J. Walsh.
Dr. Meites will share updates on CDC’s COVID-19 response, including the latest scientific information and what everyone should know about protecting themselves and others. Dr. Houry will speak about CDC's work around mental health and Ms. Kone will provide information on mental health tools and resources for state and local public health partners.
–
Every other Thursday at 4:00 PM-5:30 PM Eastern
A link to RSVP is provided shortly before each call and will be added here ASAP.
Note: You must RSVP to join the call. Upon successful registration, you will receive a confirmation email with dial-in instructions.
–
Dear Partners,
Please join us for a CDC Partner Update Call on COVID-19 Vaccines on Monday, August 30, from 6:00 – 6:45PM ET. Connection details are noted below. If you have any questions, please email eocevent424@cdc.gov.
Thank you for your partnership.
CDC COVID-19 Response CONNECTION DETAILS
You are invited to a Zoom webinar.
When: Aug 30, 2021 06:00 PM Eastern Time (US and Canada)
Topic: CDC Partner Update on COVID-19 Vaccines
Please click the link below to join the webinar:
https://cdc.zoomgov.com/j/1616725694?pwd=bmVBaGhZa0djU2FMcURpbmVTaWpFQT09
Passcode: A!0&Zd5W
Or One tap mobile:
US: +16692545252,,1616725694#,,,,*10051979# or +16468287666,,1616725694#,,,,*10051979#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 669 254 5252 or +1 646 828 7666 or +1 551 285 1373 or +1 669 216 1590
Webinar ID: 161 672 5694
Passcode: 10051979
International numbers available: https://cdc.zoomgov.com/u/aArKNw2Sa
Or an H.323/SIP room system:
H.323: 161.199.138.10 (US West) or 161.199.136.10 (US East)
Meeting ID: 161 672 5694
Passcode: 10051979
SIP: 1616725694@sip.zoomgov.com
Passcode: 10051979